Wei, J., Zhang, P., Hu, Q., Cheng, X., Shen, C., Chen, Z., . . . Liu, M. (2025). Nab-paclitaxel combined with cadonilimab (AK104) as second-line treatment for advanced gastric cancer. Frontiers in Immunology, 16, . https://doi.org/10.3389/fimmu.2025.1519545
Chicago-referens (17:e uppl.)Wei, Jing, et al. "Nab-paclitaxel Combined with Cadonilimab (AK104) as Second-line Treatment for Advanced Gastric Cancer." Frontiers in Immunology 16 (2025). https://doi.org/10.3389/fimmu.2025.1519545.
MLA-referens (9:e uppl.)Wei, Jing, et al. "Nab-paclitaxel Combined with Cadonilimab (AK104) as Second-line Treatment for Advanced Gastric Cancer." Frontiers in Immunology, vol. 16, 2025, https://doi.org/10.3389/fimmu.2025.1519545.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.
